As N.C. continues to struggle with opioid epidemic, naloxone shortage could lead to thousands of overdose deaths
In August, Pfizer halted production of its single-dose injectable naloxone, due to a manufacturing issue. This causes issues as buyers’ organizations distribute this naloxone across the state to grassroots harm
Source: journalnow.com